MetaCap

LENZ Therapeutics Statistics

NASDAQ: LENZHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

2.97-0.375 (-11.23%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

LENZ Therapeutics by the numbers

LENZ Therapeutics has a market capitalization of $93.2 million based on 31.42M shares outstanding. With trailing EPS of $-4.53, LENZ Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 18.3% below its 50-day average and 57.3% below its 200-day average.

Average daily trading volume is 892.30K shares, or about $2.6 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

LENZ valuation vs. peer median

LENZ compared with the median of 8 peer companies
MetricLENZPeer medianDifference
Market cap$93.16M$95.83M-3%
Avg. volume892.30K986.10K-10%

Peer median across 8 companies: OTLK, VYGR, IPHA, ZURA, MOLN, CRDL, BDTX, FATE.

Valuation

Market cap
$93.16M
Price / sales (latest FY)
4.88
EPS (TTM)
$-4.53

Price and trading

Previous close
3.34
Open
3.22
Day range
2.82 – 3.44
52-week range
2.80 – 32.13
52-week change
-89.97%
Beta
—
Volume
951.16K

Dividends and events

Annual dividend
None
Next earnings date
Oct 29, 2026

Additional statistics

Market Cap
93.16M
Forward Pe
-2.46
Eps
-4.53
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
32.13
Week52 Low
2.80
Avg Volume
892.30K
Shares Outstanding
31.42M
Ma50
3.63
Ma200
6.94
Earnings Date
Oct 29, 2026
Pct From52w High
-90.77%
Pct From52w Low
5.89%

Related